6
U.S. Genetic Testing Markets New Technologies Drive Genetic Testing Acceptance, Spur Market Growth “The genetic cancer testing market is ideal for micro-array/chip technologies. Once a patient has been diagnosed with a particular gene or genetic mutation, this technology has the potential to detect the levels at which the gene is being expressed.” Clinical Diagnostics Analyst Team Frost & Sullivan

U.S. Genetic Testing Markets New Technologies Drive Genetic Testing Acceptance, Spur Market Growth “The genetic cancer testing market is ideal for micro-array/chip

Embed Size (px)

Citation preview

Page 1: U.S. Genetic Testing Markets New Technologies Drive Genetic Testing Acceptance, Spur Market Growth “The genetic cancer testing market is ideal for micro-array/chip

U.S. Genetic Testing Markets

New Technologies Drive Genetic Testing Acceptance, Spur Market Growth

“The genetic cancer testing market is ideal for micro-array/chip technologies. Once a patient has been diagnosed with a particular gene or genetic mutation, this technology has the potential to detect the levels

at which the gene is being expressed.”

Clinical Diagnostics Analyst Team

Frost & Sullivan

Page 2: U.S. Genetic Testing Markets New Technologies Drive Genetic Testing Acceptance, Spur Market Growth “The genetic cancer testing market is ideal for micro-array/chip

• Detailed insights into recent developments and trends

• Drivers, restraints, challenges, and strategic recommendations

• Analyst insights into ‘hot topics’ and emerging applications in the genetic testing market.

• Market-sizing and competitive analysis

• Market forecasts and opportunity analyses

• Quarterly assessments

• End-user analysis

Key Features

Page 3: U.S. Genetic Testing Markets New Technologies Drive Genetic Testing Acceptance, Spur Market Growth “The genetic cancer testing market is ideal for micro-array/chip

• Coverage: The United States

• Proven methodology using extensive primary and secondary data as well as research

• Focused information and strategies that cover business and technology issues

• Credible data and analyses that highlight industry dynamics

• Precise strategies to help you create winning business plans

What We Offer

Page 4: U.S. Genetic Testing Markets New Technologies Drive Genetic Testing Acceptance, Spur Market Growth “The genetic cancer testing market is ideal for micro-array/chip

Current Market Participants• Find out how you compare with the competition• Assess current and future drivers as well as restraints• Determine and exploit new market share opportunities

New Entrants • Analyze the associated challenges• Calculate timescales for strategy implementation• Position yourself to capitalize on the unmet needs of the market

Investment Community• Analyze long-term strategies of companies • Determine participants that will outperform the competition• Assess the attractiveness of investing in the market

Benefits

Page 5: U.S. Genetic Testing Markets New Technologies Drive Genetic Testing Acceptance, Spur Market Growth “The genetic cancer testing market is ideal for micro-array/chip

Affymetrix, Inc.Amersham Pharmacia Biotech/Amersham plcApplied Biosystems/AppleraARUP LaboratoriesAutoGen/ Iwata Co.Baylor College of MedicineBectonDickinisonBeckman Coulter, Inc.Bio-Rad Laboratories, Inc.Cambio, Ltd.CytocellF. Hoffmann-La Roche Ltd.GeneTestsGentra Systems, Inc.

Genzyme Corp.Johns Hopkins HospitalLaboratory Corp. of AmericaLI-COR, Inc.Lifecodes Corp.Mayo Medical LaboratoriesMyriad Genetics, Inc.Promega Corp.Qiagen (USA)Quest Diagnostics, Inc.Unilab Corp.Ventana Medical Systems, Inc.Visible Genetics, Inc.Vysis, Inc.

Key Market Participants

Page 6: U.S. Genetic Testing Markets New Technologies Drive Genetic Testing Acceptance, Spur Market Growth “The genetic cancer testing market is ideal for micro-array/chip

• Call toll free 877 GO FROST

(877.463.7876)

• Fax toll free 888.690.3329

• E-mail [email protected]

• Visit www.frost.com

For More Information